Cargando…
Moxifloxacin in the Outpatient Treatment of Moderate Exacerbations of Chronic Obstructive Pulmonary Disease
BACKGROUND: Bacterial infections are involved in more than a half of the exacerbations of chronic obstructive pulmonary disease (COPD). AIM: To evaluate the efficacy and safety of moxifloxacin in the outpatient treatment of moderate exacerbations of bacterial origin in the COPD patients. METHODS: We...
Autores principales: | Minov, Jordan, Stoleski, Sasho, Petrova, Tatjana, Vasilevska, Kristin, Mijakoski, Dragan, Bislimovska-Karadzhinska, Jovanka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Republic of Macedonia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290446/ https://www.ncbi.nlm.nih.gov/pubmed/30559853 http://dx.doi.org/10.3889/oamjms.2018.445 |
Ejemplares similares
-
Effects of Pleuran (Β–Glucan from Pleurotus Ostreatus) Supplementation on Incidence and Duration of COPD Exacerbations
por: Minov, Jordan, et al.
Publicado: (2017) -
Effects of a Long-Term Use of Carbocysteine on Frequency and Duration of Exacerbations in Patients with Bronchiectasis
por: Minov, Jordan, et al.
Publicado: (2019) -
Course of COPD Assessment Test (CAT) Scores During Bacterial Exacerbations of Chronic Obstructive Pulmonary Disease Treated in Outpatient Setting
por: Minov, Jordan, et al.
Publicado: (2015) -
Job Demands, Burnout, and Teamwork in Healthcare Professionals Working in a General Hospital that Was Analysed At Two Points in Time
por: Mijakoski, Dragan, et al.
Publicado: (2018) -
Chronic Obstructive Pulmonary Disease in Never-Smoking Dairy Farmers
por: Stoleski, Saso, et al.
Publicado: (2015)